DOCSLIB.ORG

Serum Concentrations of Markers of TNF and Fas-Mediated Pathways

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Serum Concentrations of Markers of TNF and Fas-Mediated Pathways Serum Concentrations of Markers of TNF␣ and Fas-Mediated Pathways and Renal Function in Nonproteinuric Patients with Type 1 Diabetes Monika A. Niewczas,*†‡ Linda H. Ficociello,* Amanda C. Johnson,* William Walker,* Elizabeth T. Rosolowsky,*§ Bijan Roshan,* James H. Warram,* and Andrzej S. Krolewski*† *Research Division of Joslin Diabetes Center, Boston, Massachusetts; †Department of Medicine, Harvard Medical School, Boston Massachusetts; ‡Department of Immunology, Transplant Medicine and Internal Diseases, Warsaw Medical University, Warsaw, Poland; and §Division of Endocrinology, Children’s Hospital, Boston, Massachusetts Background and objectives: The aim of our study was to examine serum markers of the TNF and Fas pathways for association with cystatin-C based estimated glomerular filtration rate (cC-GFR) in subjects with type 1 diabetes (T1DM) and no proteinuria. Design, setting, participants, & measurements: The study group (the 2nd Joslin Kidney Study) comprised patients with Impaired renal function (cC-GFR <90 .(304 ؍ or microalbuminuria (MA) (n (363 ؍ T1DM and normoalbuminuria (NA) (n ml/min) was present in only 10% of patients with NA and 36% of those with MA. We measured markers of the tumor necrosis factor ␣ (TNF␣) pathway [TNF␣, soluble TNF receptor 1 (sTNFR1), and 2 (sTNFR2)], its downstream effectors [soluble intercellular and soluble vascular adhesion molecules (sICAM-1 and sVCAM-1), interleukin 8 (IL8/CXCL8), monocytes chemoattractant protein-1 (MCP1), and IFN␥ inducible protein-10 (IP10/CXCL10)], the Fas pathway [soluble Fas (sFas) and Fas ligand (sFasL)], CRP, and IL6. Results: Of these, TNF␣, sTNFRs, sFas, sICAM-1, and sIP10 were associated with cC-GFR. However, only the TNF receptors and sFas were associated with cC-GFR in multivariate analysis. Variation in the concentration of the TNF receptors had a much stronger impact on GFR than clinical covariates such as age and albumin excretion. Conclusions: Elevated concentrations of serum markers of the TNF␣ and Fas-pathways are strongly associated with decreased renal function in nonproteinuric type 1 diabetic patients. These effects are independent of those of urinary albumin excretion. Follow-up studies are needed to characterize the role of these markers in early progressive renal function decline. Clin J Am Soc Nephrol 4: 62–70, 2009. doi: 10.2215/CJN.03010608 he traditional model of the development of end-stage Low-grade chronic inflammation is thought to be involved in renal disease in type 1 diabetes mellitus (T1DM), in the pathogenesis of diabetic nephropathy (3,4). Tumor necrosis T which microalbuminuria (MA) leads to proteinuria and factor alpha (TNF␣/TNF) is a key mediator of inflammation then proteinuria is followed by renal function loss, has been and plays a role in apoptosis. In animal models, its effects on challenged recently. Increase in urinary albumin excretion is an kidneys include reduced glomerular filtration rate (GFR) and important determinant of diabetic nephropathy progression, increased albumin permeability (3). It mediates its signal via but it does not entirely explain this phenomenon. For example, two distinct receptors, TNF receptor 1 (TNFR1/TNFRSF1A) the loss of renal function commences earlier than previously and TNF receptor 2 (TNFR2/TNFRSF1B), which are mem- recognized and precedes the onset of proteinuria (1). In our brane-bound and also present in soluble form in serum (5). longitudinal study of T1DM (The First Joslin Study of Natural TNF␣ mediates its inflammatory effects by induction of a broad History of Microalbuminuria), renal function decline began spectrum of chemokines, including interleukin 8 (IL8/CXCL8); with the onset of MA in about one-third of patients and pro- monocyte chemotactic protein-1 (MCP-1/CCL2); IFN-␥ induc- gressed in a linear fashion from normal kidney function to renal ible protein-10 (IP-10/CXCL10); and adhesion molecules such insufficiency. Also, renal function decline occurred in a notice- as intercellular adhesion molecule-1 (ICAM-1) and vascular able proportion of patients with T1DM and normal albumin adhesion molecule-1 (VCAM-1) (6,7). excretion (1,2). The Fas pathway mediates apoptosis and may play a role in the progression of diabetic nephropathy (8–11). The binding of Received June 18, 2008. Accepted September 8, 2008. Fas ligand (FasL) to Fas, its membrane-bound receptor that is also present in serum in soluble form (sFasL, sFas), leads to an Published online ahead of print. Publication date available at www.cjasn.org. apoptotic response (12,13). Correspondence: Dr. Andrzej S. Krolewski, Section on Genetics and Epidemiol- ␣ ogy, Joslin Diabetes Center, One Joslin Place, Boston, MA, 02215. Phone: 617-732- Most studies on serum markers of TNF -mediated inflam- 2668; Fax: 617-732-2667; E-mail: [email protected] mation and apoptosis in diabetic nephropathy have explored Copyright © 2009 by the American Society of Nephrology ISSN: 1555-9041/401–0062 Clin J Am Soc Nephrol 4: 62–70, 2009 Markers of TNF, Fas Pathways and Renal Function 63 Table 1. Characteristics of the study group according to albuminuria statusa Characteristics Normoalbuminuria (n ϭ 363) Microalbuminuria (n ϭ 304) P AERb (␮g/min) 15 (11 to 21) 69 (45 to 131) By design Age (yr) 39 Ϯ 12 41 Ϯ 12 Ͻ0.05 Male (%) 44% 61% Ͻ0.0001 Diabetes duration (yr) 20 Ϯ 923Ϯ 10 Ͻ0.0001 HbA1cc (%) 8.3 Ϯ 1.2 8.6 Ϯ 1.5 Ͻ0.01 cC-GFRd (ml/min/1.73 m2) 118 Ϯ 24 99 Ϯ 27 Ͻ0.0001 cC-GFR categories: Ͼ130 ml/min 30% 10% 90 to 130 61% 54% 60 to 89 9% 28% Ͻ60 1% 8% aData are mean Ϯ SD, median (quartiles), or percent. bAER: median albumin excretion rate during the preceding 2-yr window cHbA1c: mean hemoglobin A1c during the preceding 2-yr window dcC-GFR: estimated GFR based on serum cystatin-C their association with MA and proteinuria rather than with be more effective if implemented 5 to 10 yr earlier in the disease GFR (14). course. The goal of this large cross-sectional study was to investigate In this study, the GFR was estimated by a cystatin C-based whether serum concentrations of markers mediated by TNF␣ formula (cC-GFR), previously shown as an accurate way of (sTNFR1, sTNFR2, sICAM-1, sVCAM-1, IL8, MCP-1, IP-10) or evaluating renal function in patients with diabetes (15,16) involved in Fas-related apoptosis (sFasL and sFas) are associ- ated, independently from albuminuria, with variation in renal Materials and Methods function in patients with T1DM who do not have proteinuria or The Committee on Human Subjects of the Joslin Diabetes Center advanced renal function impairment. This knowledge should approved the protocol and informed consent procedures for this study. facilitate the development of new diagnostic tools for identify- The study group was selected from the population attending the ing patients with early renal function decline and help the Joslin Clinic, a major center for the treatment of patients of all ages with search for intervention protocols for high-risk patients that may T1DM or type 2 diabetes mellitus (T2DM). The population is about 90% Table 2. Characteristics of the study group according to albuminuria status and group-specific median cC-GFRa Variable Normoalbuminuria Microalbuminuria Group Contrast Characteristic cC-GFR Ͼ 115 cC-GFR Ͻ 115 cC-GFR Ͼ 101 cC-GFR Ͻ 101 AER cC-GFR N 183 180 152 152 Pb Pc AER (␮g/min) 13 (10-18) 18 (12-23) 56 (42-100) 85 (51-161) By Design Ͻ0.0001 Age (yr) 37 Ϯ 11 40 Ϯ 13 36 Ϯ 12 45 Ϯ 11 Ͻ0.05 Ͻ0.0001d Diabetes duration (yr) 19 Ϯ 921Ϯ 10 20 Ϯ 926Ϯ 9 Ͻ0.0001 Ͻ0.0001d HbA1c (%) 8.3 Ϯ 1.2 8.3 Ϯ 1.2 8.7 Ϯ 1.6 8.4 Ϯ 1.4 Ͻ0.005 NS Body mass index (kg/m2) 25.6 Ϯ 3.6 26.7 Ϯ 4.3 27.2 Ϯ 4.8 27.7 Ϯ 5.2 Ͻ0.0005 Ͻ0.05 Systolic blood pressure 118 Ϯ 12 120 Ϯ 13 124 Ϯ 12 125 Ϯ 15 Ͻ0.0001 NS (mmHg) ACEI or ARB Rx (%)d 18% 21% 49% 55% Ͻ0.0001 NS Antihypertensive Rx (%) 7% 16% 14% 30% Ͻ0.001 Ͻ0.0001 Serum cholesterol 183 Ϯ 29 181 Ϯ 29 190 Ϯ 33 193 Ϯ 30 Ͻ0.0001 NS (mg/dl) Lipid-lowering Rx (%) 24% 34% 31% 42% Ͻ0.05 Ͻ0.005 Current smoker (%) 9% 12% 19% 18% Ͻ0.005 NS aData are mean Ϯ SD, median (quartiles), or %. bP-value for the albuminuria main effect in an ANOVA cP-value for the cC-GFR main effect in an ANOVA. dACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; Rx, treatment. 64 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 4: 62–70, 2009 Table 3. Serum concentrations of markers of inflammation or apoptosis according to AER group and cC-GFR above or below mediana Normoalbuminuria Microalbuminuria Group Contrast Variable cC-GFR Ͼ 115 cC-GFR Ͻ 115 cC-GFR Ͼ 101 cC-GFR Ͻ 101 AER cC-GFR (n ϭ 182) (n ϭ 181) (n ϭ 152) (n ϭ 152) Pb Pc TNF-mediated pathway TNF␣ ( pg/ml) 3.6 (2.3, 4.8) 3.9 (2.8, 5.8) 4.0 (2.6, 5.4) 4.8 (3.3, 6.4) NS Ͻ0.005 sTNFR1 (pg/ml) 1.2 (1.0, 1.4) 1.4 (1.2, 1.7) 1.4 (1.2, 1.6) 2.0 (1.6, 2.5) Ͻ0.0001 Ͻ0.0001 sTNFR2 (ng/ml) 2.1 (1.7, 2.6) 2.6 (2.1, 3.6) 2.3 (1.9, 2.9) 3.2 (2.5, 5.4) Ͻ0.0001 Ͻ0.0001 Potential downstream effectors Chemokines IL8 (pg/ml) 4.4 (2.4, 10.4) 6.1 (3.4, 13.3) 7.6 (3.8, 18.3) 7.0 (4.0, 15.5) Ͻ0.05 NS IP-10 (pg/ml) 107 (79, 136) 122 (88, 171) 102 (75, 141) 115 (80, 158) NS Ͻ0.001 MCP-1 (pg/ml) 124 (75, 184) 120 (77, 184) 113 (78, 191) 105 (77, 174) NS NS Adhesion molecule sICAM-1 (ng/ml) 133 (109, 152) 137 (119, 169) 149 (123, 173) 152 (123, 191) Ͻ0.0005 Ͻ0.005 sVCAM-1 (ng/ml) 386 (301, 481) 389 (303, 489) 376 (295, 467) 394 (330, 495) NS NS Fas-mediated pathway sFasL (pg/ml) 0.00.12 (0.08, 0.19) 0.13 (0.07, 0.20) 0.12 (08, 0.18) 0.11 (0.06, 0.16) NS NS sFas (ng/ml) 3.8 (3.0, 4.7) 4.5 (3.7, 5.5) 4.5 (3.6, 5.6) 5.4 (3.7, 6.9) Ͻ0.0001 Ͻ0.0001 Other inflammatory markers CRP (␮g/ml) 1.2 (0.5, 3.2) 1.1 (0.6, 2.7) 1.4 (0.5, 3.9) 1.6 (0.8, 3.2) Ͻ0.05 NS IL6 (pg/ml) 0.8 (0.6, 1.4) 0.9 (0.7, 1.5) 0.8 (0.4, 1.3) 0.9 (0.6, 2.2) NS NS aData are medians (quartiles); analyses were done on concentrations transformed to their logarithms.
Load more

Recommended publications
  • C-X-C Motif Chemokine Ligand 10 Produced by Mouse Sertoli Cells in Response to Mumps Virus Infection Induces Male Germ Cell Apoptosis
    Citation: Cell Death and Disease (2017) 8, e3146; doi:10.1038/cddis.2017.560 OPEN Macmillan Publishers Limited, part of Springer Nature. www.nature.com/cddis Corrected: Correction C-X-C motif chemokine ligand 10 produced by mouse Sertoli cells in response to mumps virus infection induces male germ cell apoptosis Qian Jiang1, Fei Wang1, Lili Shi1, Xiang Zhao1, Maolei Gong1, Weihua Liu1, Chengyi Song2, Qihan Li3, Yongmei Chen1, Han Wu*,1,2 and Daishu Han*,1 Mumps virus (MuV) infection usually results in germ cell degeneration in the testis, which is an etiological factor for male infertility. However, the mechanisms by which MuV infection damages male germ cells remain unclear. The present study showed that C-X-C motif chemokine ligand 10 (CXCL10) is produced by mouse Sertoli cells in response to MuV infection, which induces germ cell apoptosis through the activation of caspase-3. CXC chemokine receptor 3 (CXCR3), a functional receptor of CXCL10, is constitutively expressed in male germ cells. Neutralizing antibodies against CXCR3 and an inhibitor of caspase-3 activation significantly inhibited CXCL10-induced male germ cell apoptosis. Furthermore, the tumor necrosis factor-α (TNF-α) upregulated CXCL10 production in Sertoli cells after MuV infection. The knockout of either CXCL10 or TNF-α reduced germ cell apoptosis in the co-cultures of germ cells and Sertoli cells in response to MuV infection. Local injection of MuV into the testes of mice confirmed the involvement of CXCL10 in germ cell apoptosis in vivo. These results provide novel insights into MuV-induced germ cell apoptosis in the testis.
    [Show full text]
  • Critical Role of CXCL4 in the Lung Pathogenesis of Influenza (H1N1) Respiratory Infection
    ARTICLES Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection L Guo1,3, K Feng1,3, YC Wang1,3, JJ Mei1,2, RT Ning1, HW Zheng1, JJ Wang1, GS Worthen2, X Wang1, J Song1,QHLi1 and LD Liu1 Annual epidemics and unexpected pandemics of influenza are threats to human health. Lung immune and inflammatory responses, such as those induced by respiratory infection influenza virus, determine the outcome of pulmonary pathogenesis. Platelet-derived chemokine (C-X-C motif) ligand 4 (CXCL4) has an immunoregulatory role in inflammatory diseases. Here we show that CXCL4 is associated with pulmonary influenza infection and has a critical role in protecting mice from fatal H1N1 virus respiratory infection. CXCL4 knockout resulted in diminished viral clearance from the lung and decreased lung inflammation during early infection but more severe lung pathology relative to wild-type mice during late infection. Additionally, CXCL4 deficiency decreased leukocyte accumulation in the infected lung with markedly decreased neutrophil infiltration into the lung during early infection and extensive leukocyte, especially lymphocyte accumulation at the late infection stage. Loss of CXCL4 did not affect the activation of adaptive immune T and B lymphocytes during the late stage of lung infection. Further study revealed that CXCL4 deficiency inhibited neutrophil recruitment to the infected mouse lung. Thus the above results identify CXCL4 as a vital immunoregulatory chemokine essential for protecting mice against influenza A virus infection, especially as it affects the development of lung injury and neutrophil mobilization to the inflamed lung. INTRODUCTION necrosis factor (TNF)-a, interleukin (IL)-6, and IL-1b, to exert Influenza A virus (IAV) infections cause respiratory diseases in further antiviral innate immune effects.2 Meanwhile, the innate large populations worldwide every year and result in seasonal immune cells act as antigen-presenting cells and release influenza epidemics and unexpected pandemic.
    [Show full text]
  • Ncomms1239.Pdf
    ARTICLE Received 10 Nov 2010 | Accepted 15 Feb 2011 | Published 15 Mar 2011 DOI: 10.1038/ncomms1239 Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer Ole Audun Werner Haabeth1, Kristina Berg Lorvik1, Clara Hammarström2, Ian M. Donaldson3,4, Guttorm Haraldsen2, Bjarne Bogen1 & Alexandre Corthay1 The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and IL-6 are considered to be tumour promoting. In contrast, the exact nature of protective antitumour immunity remains obscure. Here, we quantify locally secreted cytokines during primary immune responses against myeloma and B-cell lymphoma in mice. Strikingly, successful cancer immunosurveillance mediated by tumour-specific CD4 + T cells is consistently associated with elevated local levels of both proinflammatory (IL-1α, IL-1β and IL-6) and T helper 1 (Th1)-associated cytokines (interferon-γ (IFN-γ), IL-2 and IL-12). Cancer eradication is achieved by a collaboration between tumour- specific Th1 cells and tumour-infiltrating, antigen-presenting macrophages. Th1 cells induce secretion of IL-1β and IL-6 by macrophages. Th1-derived IFN-γ is shown to render macrophages directly cytotoxic to cancer cells, and to induce macrophages to secrete the angiostatic chemokines CXCL9/MIG and CXCL10/IP-10. Thus, inflammation, when driven by tumour- specific Th1 cells, may prevent rather than promote cancer. 1 Centre for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, PO Box 4950 Nydalen, 0424 Oslo, Norway. 2 Department of Pathology, Institute of Pathology, Oslo University Hospital Rikshospitalet and University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway.
    [Show full text]
  • Establishment of HIV-1 Latency in Resting CD4+ T Cells Depends on Chemokine-Induced Changes in the Actin Cytoskeleton
    Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton Paul U. Camerona,b,c,1, Suha Salehb,1, Georgina Sallmannb, Ajantha Solomonb, Fiona Wightmanb, Vanessa A. Evansb, Genevieve Boucherd, Elias K. Haddadd,Rafick-Pierre Sekalyd, Andrew N. Harmane, Jenny L. Andersonf, Kate L. Jonesf, Johnson Makf,g, Anthony L. Cunninghame, Anthony Jaworowskib,c,f, and Sharon R. Lewina,b,f,2 aInfectious Diseases Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia; Departments of bMedicine and cImmunology, Monash University, Melbourne 3004, Australia; dLaboratoire d’Immunologie, Centre de Recherche de Centre Hospitalier de L’Universitie de Montreal, Saint-Luc, Quebec, Canada; eWestmead Millenium Research Institute, Westmead 2145, Australia; fCentre for Virology, Burnet Institute, Melbourne 3004, Australia; and gDepartment of Biochemistry and Molecular Biology, Department of Microbiology, Monash University, Clayton 3800, Australia Edited by Malcolm A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved August 23, 2010 (received for review March 8, 2010) Eradication of HIV-1 with highly active antiretroviral therapy mokines, in addition to CXCR4 ligands may facilitate HIV-1 + (HAART) is not possible due to the persistence of long-lived, entry and integration in resting CD4 T cells and that this was latently infected resting memory CD4+ T cells. We now show that mediated via activation of actin. + HIV-1 latency can be established in resting CD4+ T cells infected We now show that the exposure of resting CD4 T cells to with HIV-1 after exposure to ligands for CCR7 (CCL19), CXCR3 the chemokines CCL19, CXCL10, and CCL20, all of which fi (CXCL9 and CXCL10), and CCR6 (CCL20) but not in unactivated regulate T-cell migration, allows for ef cient HIV-1 nuclear lo- + calization and integration of the HIV-1 provirus, that this oc- CD4 T cells.
    [Show full text]
  • Expression and Analysis of CXCL8 and CXCL10 Chemokines In
    erial D act is b ea o s c e y s M Mycobacterial Diseases Rawat et al., Mycobact Dis 2016, 6:2 DOI: 10.4172/2161-1068.1000208 ISSN: 2161-1068 Research an open access journal Expression and Analysis of CXCL8 and CXCL10 Chemokines in Human Skin Lesions Infected with M.leprae Krishan Dutta Rawat1, Mamta Chahar1, PVJ Reddy1, Nalini Srivastava2, U.D.Gupta1, M. Natrajan1, V.M. Katoch3, Kiran Katoch1 and D.S. Chauhan1* 1National JALMA Institute for Leprosy & Other Mycobacterial Diseases Tajganj, Agra, U.P, India 2SOS in Biotechnology, Jiwaji University, Gwalior, M.P, India. 3Department of Health Research, Indian Council of Medical Research, Ansari Nagar, New Delhi, India *Corresponding author: Chauhan DS, Microbiology & Molecular biology Lab, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, (ICMR) Tajganj, Agra-282001, Tel: (0562) 2331751-4; Fax: +91-562-2331755; E-mail: [email protected] Rec date: February 02, 2016; Acc date: May 19, 2016; Pub date: May 24, 2016 Copyright: © 2016 Rawat KD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract This study is focused to analyze the expression profile of CXCL8 and CXCL10 chemokines genes and to address the contribution of these chemokines in late phase of M.leprae infection in human skin lesion samples. In this study skin biopsy samples from leprosy patients (n=35) were collected including BL-LL=12, BB=14, BT=8 and healthy volunteers (n=3).
    [Show full text]
  • Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes Suparna A
    ORIGINAL ARTICLE Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes Suparna A. Sarkar,1 Catherine E. Lee,1 Francisco Victorino,1,2 Tom T. Nguyen,1 Jay A. Walters,1 Adam Burrack,1,2 Jens Eberlein,1 Steven K. Hildemann,3 and Dirk Homann1,2,4 fl – More than one-half of the ~50 human chemokines have been in ammation (1 3), and multiple chemokines and chemokine associated with or implicated in the pathogenesis of type 1 receptors have emerged as pertinent contributors to the diabetes, yet their actual expression patterns in the islet environ- natural history of various autoimmune disorders, including ment of type 1 diabetic patients remain, at present, poorly defined. type 1 diabetes; potential biomarkers; and possible drug Here, we have integrated a human islet culture system, murine targets (4–8). In fact, work conducted over the past 20 models of virus-induced and spontaneous type 1 diabetes, and the years has implicated more than one-half of all human and/ histopathological examination of pancreata from diabetic organ or rodent chemokines in the pathogenesis of type 1 diabetes donors with the goal of providing a foundation for the informed and/or its complications, although much of the work pub- selection of potential therapeutic targets within the chemokine/ receptor family. Chemokine (C-C motif) ligand (CCL) 5 (CCL5), lished to date on human type 1 diabetes and chemokines CCL8, CCL22, chemokine (C-X-C motif) ligand (CXCL) 9 (CXCL9), remains limited to genetic association studies and che- CXCL10, and chemokine (C-X3-C motif) ligand (CX3CL) 1 (CX3CL1) mokine/receptor analyses in peripheral blood (9–23).
    [Show full text]
  • Human CXCL4/PF4 Immunoassay Quantikine
    Quantikine® ELISA Human CXCL4/PF4 Immunoassay Catalog Number DPF40 For the quantitative determination of human Platelet Factor 4 (PF4) concentrations in cell culture supernates, serum, and platelet-poor plasma. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION ....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ..................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE ................................................................................................................................2 TECHNICAL HINTS ................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ..................................................................................................3 OTHER SUPPLIES REQUIRED ............................................................................................................................................3 PRECAUTIONS ........................................................................................................................................................................4 SAMPLE
    [Show full text]
  • Baseline CXCL10 and CXCL13 Levels Are Predictive Biomarkers for Tumor Necrosis Factor Inhibitor Therapy in Patients with Moderat
    Han et al. Arthritis Research & Therapy (2016) 18:93 DOI 10.1186/s13075-016-0995-0 RESEARCH ARTICLE Open Access Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study Bobby Kwanghoon Han1*, Igor Kuzin2, John P. Gaughan3, Nancy J. Olsen4 and Andrea Bottaro2 Abstract Background: TNF inhibitors have been used as a treatment for moderate to severe RA patients. However, reliable biomarkers that predict therapeutic response to TNF inhibitors are lacking. In this study, we investigated whether chemokines may represent useful biomarkers to predict the response to TNF inhibitor therapy in RA. Methods: RA patients (n = 29) who were initiating adalimumab or etanercept were recruited from the rheumatology clinics at Cooper University Hospital. RA patients were evaluated at baseline and 14 weeks after TNF inhibitor therapy, and serum levels of CXCL10, CXCL13, and CCL20 were measured by ELISA. Responders (n = 16) were defined as patients who had good or moderate response at week 14 by EULAR response criteria, and nonresponders (n = 13) were defined as having no response. Results: Responders had higher levels of baseline CXCL10 and CXCL13 compared to nonresponders (p =0.03 and 0.002 respectively). There was no difference in CCL20 levels. CXCL10 and CXCL13 were highly correlated with each other, and were higher in seropositive RA patients. CXCL10 and CXCL13 levels were decreased after TNF inhibitor therapy in responders. Baseline additive levels of CXCL10 + 13 were correlated with changes in DAS score at 14 weeks after TNF inhibitor therapy (r = 0.42, p = 0.03), and ROC curve analyses for predictive ability of CXCL10 + 13 showed an AUC of 0.83.
    [Show full text]
  • Glial Cell Activation, Recruitment, and Survival of B-Lineage Cells Following MCMV Brain Infection James R
    Lokensgard et al. Journal of Neuroinflammation (2016) 13:114 DOI 10.1186/s12974-016-0582-y RESEARCH Open Access Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection James R. Lokensgard*, Manohar B. Mutnal, Sujata Prasad, Wen Sheng and Shuxian Hu Abstract Background: Chemokines produced by reactive glia drive migration of immune cells and previous studies from our laboratory have demonstrated that CD19+ B cells infiltrate the brain. In this study, in vivo and in vitro experiments investigated the role of reactive glial cells in recruitment and survival of B-lineage cells in response to (murine cytomegalovirus) MCMV infection. Methods: Flow cytometric analysis was used to assess chemokine receptor expression on brain-infiltrating B cells. Real-time RT-PCR and ELISA were used to measure chemokine levels. Dual-immunohistochemical staining was used to co-localize chemokine production by reactive glia. Primary glial cell cultures and migration assays were used to examine chemokine-mediated recruitment. Astrocyte: B cell co-cultures were used to investigate survival and proliferation. Results: The chemokine receptors CXCR3, CXCR5, CCR5, and CCR7 were detected on CD19+ cells isolated from the brain during MCMV infection. In particular, CXCR3 was found to be elevated on an increasing number of cells over the time course of infection, and it was the primary chemokine receptor expressed at 60 days post infection Quite different expression kinetics were observed for CXCR5, CCR5, and CCR7, which were elevated on the highest number of cells early during infection and decreased by 14, 30, and 60 days post infection Correspondingly, elevated levels of CXCL9, CXCL10, and CXCL13, as well as CCL5, were found within the brains of infected animals, and only low levels of CCL3 and CCL19 were detected.
    [Show full text]
  • The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are
    viruses Article The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner Victoria Callahan 1, Seth Hawks 2, Matthew A. Crawford 3 , Caitlin W. Lehman 2 , Holly A. Morrison 2 , Hannah M. Ivester 4, Ivan Akhrymuk 2, Niloufar Boghdeh 1, Rafaela Flor 1, Carla V. Finkielstein 5 , Irving Coy Allen 2,6,7, James Weger-Lucarelli 2,7, Nisha Duggal 2,7, Molly A. Hughes 3 and Kylene Kehn-Hall 1,2,7,* 1 National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA 20110, USA; [email protected] (V.C.); [email protected] (N.B.); mfl[email protected] (R.F.) 2 Department of Biomedical Science and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060, USA; [email protected] (S.H.); [email protected] (C.W.L.); [email protected] (H.A.M.); [email protected] (I.A.); [email protected] (I.C.A.); [email protected] (J.W.-L.); [email protected] (N.D.) 3 Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA; [email protected] (M.A.C.); [email protected] (M.A.H.) Citation: Callahan, V.; Hawks, S.; 4 Graduate Program in Translational Biology, Medicine and Health, Virginia Polytechnic Institute and State Crawford, M.A.; Lehman, C.W.; University, Roanoke, VA 24061, USA; [email protected] 5 Morrison, H.A.; Ivester, H.M.; Integrated Cellular Responses Laboratory, Department of Biological Sciences and Center for Drug Discovery, Akhrymuk, I.; Boghdeh, N.; Flor, R.; Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University, Roanoke, VA 24016, USA; fi[email protected] Finkielstein, C.V.; et al.
    [Show full text]
  • The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus
    Inflammation, Vol. 42, No. 3, June 2019 ( # 2018) DOI: 10.1007/s10753-018-0934-0 ORIGINAL ARTICLE The Expression of CXCL10/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus Jiaxiang Fang,1,2 Chen Wang,1,2 Chen Shen,3 Jing Shan,1,2 Xuewei Wang,1,2 Lin Liu,1,2 and Yuan Fan1,2,4 Abstract— The etiology of oral lichen planus (OLP) is still not clear. The purpose of this study was to explore the role of CXC chemokine receptor 3(CXCR3) and its ligand CXC motif chemokine 10(CXCL10) in the pathogenesis of OLP. We examined the expression of CXCR3 and CXCL10 in OLP patients and healthy controls by quantitative real-time PCR, Western blotting, ELISAs, and immunohistochemistry, respectively. Moreover, we detected the effects of CXCL10/CXCR3 axis on T lymphocyte migration, proliferation and apoptosis by Trans- well assays, CCK8 assays, and flow cytometry. We found that the expression of CXCR3 and CXCL10 was significantly increased in OLP patients. In addition, T lymphocyte migration rate of CXCL10 stimulation group was significantly higher than that of control and CXCR3 antagonist groups. After antagonizing CXCR3, the migration ability of T lymphocytes was significantly decreased, and regardless of whether CXCL10 was added in the upper chamber culture medium, the number of migrating cells was similar. The addition of CXCL10 stimulant could stimulate the proliferation of T lymphocytes, but there was no significant difference compared with control group. After antagonizing CXCR3, the proliferation rate of T lymphocytes was significantly reduced. However, there were no significant differences in the apoptosis rates of T lymphocytes between CXCL10 stimulation group, antagonist CXCR3 group, and control group.
    [Show full text]
  • Fas Ligand Promotes an Inducible TLR-Dependent Model of Cutaneous Lupus-Like Inflammation
    University of Massachusetts Medical School eScholarship@UMMS University of Massachusetts Medical School Faculty Publications 2018-06-11 Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation Purvi Mande University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/faculty_pubs Part of the Dermatology Commons, Immune System Diseases Commons, Immunity Commons, Immunopathology Commons, Rheumatology Commons, and the Skin and Connective Tissue Diseases Commons Repository Citation Mande P, Zirak B, Ko W, Taravati K, Bride KL, Brodeur TB, Deng AC, Dresser KA, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, Marshak-Rothstein A. (2018). Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1172/JCI98219. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1581 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in University of Massachusetts Medical School Faculty Publications by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Fas ligand promotes an inducible TLR- dependent model of cutaneous lupus–like inflammation Purvi Mande, … , John E. Harris, Ann Marshak-Rothstein J Clin Invest. 2018;128(7):2966-2978. https://doi.org/10.1172/JCI98219. Research Article Autoimmunity Dermatology Toll-like receptors TLR7 and TLR9 are both implicated in the activation of autoreactive B cells and other cell types associated with systemic lupus erythematosus (SLE) pathogenesis. However, Tlr9–/– autoimmune-prone strains paradoxically develop more severe disease.
    [Show full text]